Surface expression of CD57 was measured as a marker for NK cell maturation on CD56dimCD16+ and CD56brightCD16dim/− NK cells and no significant differences were observed between the CFS/ME patients and the NFC (Additional file 3: Figures S13, S14). The gene discussed is B3GAT1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.